55304-73-9 Usage
General Description
2,6-Dichloropyridine-3-carboxaldehyde is a chemical compound with the molecular formula C7H3Cl2NO. It is an aromatic aldehyde with a pyridine ring and two chlorine atoms attached to the 2 and 6 positions. 2 6-DICHLOROPYRIDINE-3-CARBOXALDEHYDE is commonly used as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. It is also used as a building block for the production of various heterocyclic compounds. 2,6-Dichloropyridine-3-carboxaldehyde is known for its strong and pungent odor, and it is important to handle it with care due to its potential hazards and irritant properties.
Check Digit Verification of cas no
The CAS Registry Mumber 55304-73-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,5,3,0 and 4 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 55304-73:
(7*5)+(6*5)+(5*3)+(4*0)+(3*4)+(2*7)+(1*3)=109
109 % 10 = 9
So 55304-73-9 is a valid CAS Registry Number.
InChI:InChI=1/C6H3Cl2NO/c7-5-2-1-4(3-10)6(8)9-5/h1-3H
55304-73-9Relevant articles and documents
Nicotinic Acid Crown Ethers. An Unexpected Facile Etherification Process
Newkome, George R.,Hyo-Won Lee
, p. 2800 - 2802 (1982)
-
PRMT5 INHIBITORS AND USES THEREOF
-
, (2014/07/08)
Described herein are compounds of Formula (A), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting PRMT5 activity. Methods of using the compounds for treating PRMT5-mediated disorders are also described
CHEMOKINE RECEPTOR BINDING COMPOUNDS
-
Page/Page column 61-62, (2010/11/26)
The present invention relates to chemokine receptor binding compounds, pharmaceutical compositions and their use. More specifically, the present invention relates to modulators of chemokine receptor activity, preferably modulators of CCR4 or CCR5. In one aspect, these compounds demonstrate protective effects against infection of target cells by a human immunodeficiency virus (HIV).